6 March 2023

Spain to co-host 2023 Vaccine Alliance High-Level Summit on Immunisation

The high-level summit, co-hosted by Gavi and Spain, will be an opportunity to look back on the immunisation strategy outlined by the Vaccine Alliance at 2020’s Global Vaccine Summit in London.

13 February 2023

Dr Muhammad Ali Pate to become next CEO of Gavi, the Vaccine Alliance

The Gavi Board has approved the appointment of Dr Muhammad Ali Pate as the Chief Executive Officer of the Vaccine Alliance following an extensive recruitment process.

7 February 2023

Gavi welcomes appointment of global health leader and malaria expert Dr Rose Leke as Chair of Independent Review Committee

The Gavi Independent Review Committee (IRC) is responsible for reviewing all applications for new funding support submitted by Gavi-eligible countries.

3 February 2023

Gavi and Government of India establish new partnership to protect millions of children by 2026

Gavi will provide US$ 250 million in funding to reach zero-dose children – those who have not received a single routine vaccine shot – through a renewed strategic partnership with the Government of India

25 January 2023

COVID-19 Vaccine Delivery Partnership boosts Sierra Leone COVID-19 Vaccination with US$ 2.8 million worth donation

COVID-19 Vaccine Delivery Partnership, (CoVDP) has handed over vehicles, motorbikes and computers worth of US$ 2.8M to support Sierra Leone Vaccination efforts.

19 January 2023

The US$ 500 million challenge: Gavi launches INFUSE 2.0 to scale up innovations in immunisation

INFUSE is an innovation scaling hub that matches investors with innovators and entrepreneurs to help scale up new ways to improve vaccination coverage in lower-income countries

19 January 2023

Gavi, Unilever Lifebuoy and The Power of Nutrition join forces in tripartite immunisation, handwashing and nutrition programme to tackle preventable diseases

Gavi’s first multisectoral private sector partnership to include nutrition as part of holistic approach to disease prevention.

8 December 2022

Gavi Board Decisions Outline “Year of Renewal” for Vaccine Alliance

Board underlines commitment to end backsliding in routine immunisation, catching up coverage and reaching zero-dose children as the Vaccine Alliance’s core priorities for the remainder of the current 2020–2025 strategic period.

3 November 2022

Global health agencies outline plan to support Ugandan government-led response to outbreak of Ebola virus disease

3 November 2022 – Following the declaration of an Ebola outbreak in Uganda on 20 September 2022, the outbreak has now spread to seven districts (Kasanda, Kyegegwa, Bunyangabu and Kagadi districts beyond the original epicenter in Mubende district…

3 November 2022

Gavi sets course to support sustainable vaccine manufacturing in Africa with new action plan in support of the African Union’s 2040 vision

Gavi publishes plan of action to support the development of sustainable vaccine manufacturing in Africa.

28 October 2022

Lower-income countries push to reach more than 85 million children with measles vaccine

Following an alarming global rise in measles cases and outbreaks, lower Income countries are accelerating efforts with support from Gavi, the Vaccine Alliance.

17 October 2022

Gavi, Moderna update COVAX supply agreement; agree on access to variant-containing vaccines for lower-income countries

Gavi and Moderna agree to cancel remaining volumes under existing COVAX supply agreement.

Last updated: 25 Feb 2021

Subscribe to our newsletter